Summary
Latest filing:
Claude Maraoui is President & CEO, Director of Journey Medical Corp (DERM). 2 SEC Form 4 filings on record going back to 2025, most recently on 24 April 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Claude Maraoui has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Claude Maraoui's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- QVT Financial LP - $147.38M of ROIV open-market activity in the last 12 months
- ULSE Inc. - $146.25M of ULS open-market activity in the last 12 months
- BAIN CAPITAL INVESTORS LLC - $134.38M of KLRA open-market activity in the last 12 months
- Andrew T. Kaplan - $134.38M of KLRA open-market activity in the last 12 months
- Fairmount Funds Management LLC - $133.53M of APGE open-market activity in the last 12 months
- Jason P. Rhodes - $124.92M of DYN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Claude Maraoui?
Claude Maraoui is a corporate insider, tracked as President & CEO, Director of Journey Medical Corp (DERM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Claude Maraoui last file a Form 4?
The most recent primary Form 4 on record is dated 24 April 2026, one of 2 filings going back to 2025.
Where can I see all of Claude Maraoui's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Claude Maraoui and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
